N-terminal pro-brain natriuretic peptide from fresh urine for the biochemical detection of heart failure and left ventricular dysfunction

European Journal of Heart Failure

Volumn 12, Issue 4, 2010, Pages 331-337

  Jungbauer, Carsten G ^a   Buchner, Stefan ^a   Birner, Christoph ^a   Resch, Markus ^a   Heinicke, Norbert ^a   Debl, Kurt ^a   Buesing, Monika ^a   Biermeier, Daniela ^a   Schmitz, Gerd ^a   Riegger, Günter ^a   Luchner, Andreas ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Cardiac markers; Heart failure; Natriuretic peptides; Urinary NT proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CARDIAC PATIENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; FLUID RETENTION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; SENSITIVITY AND SPECIFICITY; URINALYSIS;

BIOLOGICAL MARKERS; CONFIDENCE INTERVALS; FEASIBILITY STUDIES; FEMALE; FLUID THERAPY; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 77950240290     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq016     Document Type: Article

References (24)

1. Nielsen LS, Svangegaard J, Klitgaard NA, Egeblad H. N-terminal pro-brain natriuretic peptide for discrimination between cardiac and non-cardiac dyspnoe. Eur J Heart failure 2004;6:63-70.
2. Richards M, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, Frampton CM, Crozier IG, Yandle TG, Doughty R, MacMahon S, Sharpe N. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease. J Am Coll Cardiol 2006;47:52-60.
3. Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol 1997;47:287-296.
4. Hammerer-Lercher A, Ludwig W, Falkensammer G, Müller S, Neubauer E, Puschendorf B, Pachinger O, Mair J. Natriuretic peptides as markers of mild forms of left ventricular dysfunction: effects of assay on diagnostic performance of markers. Clin Chem 2004;50:1174-1183.
5. Luchner A, Hengstenberg C, Löwel H, Trawinski J, Baumann M, Riegger GA, Schunkert H, Holmer S. N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function. Hypertension 2002;39:99-104.
6. Luchner A, Hengstenberg C, Löwel H, Buchner S, Schunkert H, Riegger GA, Holmer S. NT-proBNP in outpatients after myocardial infarction: interaction between symptoms and left ventricular function and optimized cut-points. J Card Fail 2005;11:S21-S27.
7. Luchner A, Hengstenberg C, Lowel H, Riegger GA, Schunkert H, Holmer S. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension 2005;46:118-123.
8. Andreassi MG, Del Ry S, Palmieri C, Clerico A, Biagini A, Giannessi D. Up-regulation of 'clearance' receptors in patients with chronic heart failure: a possible explanation for the resistance to biological effects of cardiac natriuretic hormones. Eur J Heart Fail 2001;3:407-414.
9. Hystad ME, Oie E, Grøgaard HK, Kuusnemi K, Vuolteenaho O, Attramadal H, Hall C. Gene expression of natriuretic peptides and their receptors type-A and-C after myocardial infarction in rats. Scand J Clin Lab Invest 2001;61:139-150.
10. Goetze JP, Jensen G, Møller S, Bendtsen F, Rehfeld JF, Henriksen JH. BNP and N-terminal proBNP are both extracted in the normal kidney. Eur J Clin Invest 2006; 36:8-15.
11. Vesely DL. Natriuretic peptides and acute renal failure. Am J Physiol Renal Physiol 2003;285:167-177.
12. Hall C. Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 2004;6:257-260.
13. Ng LL, Geeranavar RS, Jennings SC, Loke I, O'Brien RJ. Diagnosis of heart failure using urinary natriuretic peptides. Clin Sci 2004;106:129-133.
14. Ng LL, Loke IW, DaviesJE, Geeranavar S, Khunti K, Stone MA, Chin DT, Squire IB. Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptides. J Am Coll Cardiol 2005;45:1043-1050.
15. Cortes R, Portoles M, Salvador A, Bertomeu V, Garćia de Burgos F, Mart́inez-Dolz L, Llet́i ER, Climent V, Jordan A, Paya R, Sogorb F, Rivera M. Diagnostic and prognostic value of urine NT-proBNP levels in heart failure patients. Eur J Heart Fail 2006;8:621-627.
16. Cortes R, Rivera M, Salvador A, Bertomeu V, de Burgos FG, Rosello-Llet́i E, Portoles M, Paya R, Mart́inez-Dolz L, Climent V. Variability of NT-proBNP plasma and urine levels in patients with stable heart failure: a 2-year follow-up study. Heart 2007;93:957-962.
17. Linssen GC, Damman K, Hillege HL, Navis G, van Veldhuisen DJ, Voors AA Urinary N-terminal prohormone brain natriuretic peptide excretion in patients with chronic heart failure. Circulation 2009;120:35-41.
18. Michielsen EC, Bakker JA, Kimmenade RR, Pinto YM, Dieijen-Visser MP. The diagnostic value of serum and urinary NT-proBNP for heart failure. Ann Clin Biochem 2008;45:389-394.
19. Rosello-Llet́i E, Rivera M, Miro V, Mora V, Cortes R, Lauwers C, Valero R, Sevilla B, Sogorb F, Morillas P, Garćia de Burgos F, Portoles M. Urinary NT-proBNP level: relationship with ventricular function parameters in heart failure. Rev Esp Cardiol 2007;60:510-516.
20. Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005;46:e1-e82.
21. Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348:2007-2018.
22. Troughton RW, Prior DL, Pereira JJ, Martin M, Fogarty A, Morehead A, Yandle TG, Richards AM, Starling RC, Young JB, Thomas JD, Klein AL. Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol 2004;43:416-422.
23. Chen AA, Wood MJ, Krauser DG, Baggish AL, Tung R, Anwaruddin S, Picard MH, Januzzi JL. NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the proBNP Investigation of Dyspnea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J 2006;27:839-845.
24. Talwar S, Siebenhofer A, Williams B, Ng L. Influence of hypertension, left ventricular hypertrophy and left ventricular systolic dysfunction on plasma N-terminal proBNP. Heart 2000;83:278-282.